| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/25/1996 | WO1996001644A1 Inhibitors of leukocyte adhesion |
| 01/25/1996 | WO1996001643A1 IgE ANTAGONISTS |
| 01/25/1996 | WO1996001642A1 Tumor necrosis factor receptor-ii-associated protein kinase and methods for its use |
| 01/25/1996 | WO1996001636A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | WO1996001611A1 Implanted device containing tumor cells for the treatment of cancer |
| 01/25/1996 | WO1996001561A1 Method of regulating immune function |
| 01/25/1996 | WO1996001557A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 01/25/1996 | WO1995032221A3 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 01/25/1996 | WO1995030439A3 Prevention of tumor metastasis |
| 01/25/1996 | WO1995030438A3 Methods and compositions to enhance endogenous fibrinolytic activity |
| 01/25/1996 | DE4426165A1 Treating liver dysfunction or parenchyma damage |
| 01/25/1996 | CA2194895A1 Anti-protozoan methods and materials |
| 01/25/1996 | CA2194768A1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/25/1996 | CA2194765A1 Connective tissue growth factor-2 |
| 01/25/1996 | CA2194678A1 Use of muramyl peptide compounds |
| 01/25/1996 | CA2194566A1 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 01/25/1996 | CA2194560A1 Cascade-polymer complexes and methods of producing the same |
| 01/25/1996 | CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | CA2194548A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 01/25/1996 | CA2194451A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 01/25/1996 | CA2194447A1 Recombinant kat enzyme and process for its preparation |
| 01/25/1996 | CA2194443A1 Method of attenuating arterial stenosis |
| 01/25/1996 | CA2194366A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | CA2194299A1 Novel cytokine designated lerk-5 |
| 01/25/1996 | CA2193508A1 Inhibitors of leukocyte adhesion |
| 01/25/1996 | CA2193263A1 Adenovirus comprising a gene coding for an no synthase |
| 01/24/1996 | EP0693287A1 RNA cleaving or binding oligonucleotides |
| 01/24/1996 | EP0693286A1 Pharmaceutical composition comprising furin |
| 01/24/1996 | EP0693277A1 Method for obstructing lacrimal canaliculi with infusible solution or dispersion |
| 01/24/1996 | EP0693129A1 Method of inhibiting the transcription of genes |
| 01/24/1996 | EP0693126A1 Method for selective inactivation of viral replication |
| 01/24/1996 | EP0693122A1 Glutamylcysteine synthetase light subunit |
| 01/24/1996 | EP0693084A1 Chimeric cytokine receptors in lymphocytes |
| 01/24/1996 | EP0693083A1 Alpha-ketoamide derivatives as inhibitors of thrombosis |
| 01/24/1996 | EP0693082A1 Immuno modulated peptide derivatives of leukokinin fragments |
| 01/24/1996 | EP0693081A1 Cyclic compounds and compositions which inhibit bone resorption |
| 01/24/1996 | EP0692984A1 Systemic effects of nitric oxide inhalation |
| 01/24/1996 | EP0692982A1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS |
| 01/24/1996 | EP0692981A1 Chelators of type xn 1?s 1?x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses |
| 01/24/1996 | EP0692980A1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use |
| 01/24/1996 | EP0692979A1 Bifunctional chelators and their use in radiopharmaceuticals |
| 01/24/1996 | EP0692972A1 Method for delivering beneficial compositions to hair follicles |
| 01/24/1996 | EP0692971A1 Analogs of peptide yy and uses thereof |
| 01/24/1996 | EP0692970A1 Method for reducing the viscosity of pathological mucoid airway contents in the respiratoy tract |
| 01/24/1996 | EP0692969A1 Method of treatment of diseases by deletion of t cells |
| 01/24/1996 | EP0692968A1 Urokinase plasminogen activator fragments |
| 01/24/1996 | EP0692967A1 Method of inhibiting radiation induced weight and hair loss |
| 01/24/1996 | EP0692966A1 A process for separation of components from red blood cells |
| 01/24/1996 | EP0692963A1 Use of terbinafine for the therapeutic treatment of pneumocystosis |
| 01/24/1996 | EP0692931A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
| 01/24/1996 | EP0692930A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 01/24/1996 | EP0631617A4 Colon crypt cell mitogen, cell line producing it, and uses thereof. |
| 01/24/1996 | EP0451216B1 Humanized immunoglobulins and their production and use |
| 01/24/1996 | CN1115253A Eye drops |
| 01/24/1996 | CN1115252A Ionic molecular conjugates of biodergaable polyesters and bioactive polypeptides |
| 01/23/1996 | US5486623 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 01/23/1996 | US5486602 Genes encoding serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors |
| 01/23/1996 | US5486599 Construction and use of synthetic constructs encoding syndecan |
| 01/23/1996 | US5486595 Tumor necrosis factor inhibitors |
| 01/23/1996 | US5486529 Certain pyridyl ketones for treating diseases involving leukocyte elastase |
| 01/23/1996 | US5486513 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors or enkephalinase and ace |
| 01/23/1996 | US5486509 Method of preventing and treating chemotherapy-induced alopecia |
| 01/23/1996 | US5486505 Polypeptide compounds having growth hormone releasing activity |
| 01/23/1996 | US5486503 Anti-fungal histatin-based peptides |
| 01/23/1996 | US5486471 Expression vectors and dna sequences |
| 01/23/1996 | US5486466 Enzyme inhibitors |
| 01/23/1996 | US5486463 TNF-muteins |
| 01/23/1996 | US5486361 Hybridomas and monoclonal antibodies that speifically bind to GPIB on platelets and inhibit the binding of thrombin to platelets |
| 01/23/1996 | US5486360 Method of treating tumour cells using catalase |
| 01/23/1996 | CA2154403A1 A novel osteoblast proliferative factor |
| 01/23/1996 | CA2154379A1 Parietaria allergens |
| 01/23/1996 | CA1337976C Insulin precursors |
| 01/19/1996 | EP0702553A4 Water soluble non-immunogenic polyamide cross-linking agents |
| 01/18/1996 | WO1996001430A2 Screening for nuc inhibitors |
| 01/18/1996 | WO1996001429A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/18/1996 | WO1996001329A1 Methods for diagnosing an immune-related disease and choosing an immune-related therapy |
| 01/18/1996 | WO1996001322A1 Serum paraoxonase |
| 01/18/1996 | WO1996001319A1 Variants of leukemia inhibitory factor |
| 01/18/1996 | WO1996001318A1 Immunomodulators |
| 01/18/1996 | WO1996001316A1 NOVEL GROWTH OR DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 01/18/1996 | WO1996001312A1 Non-glycosylated plasminogen activator derivatives and their use in conditions involving a high risk of bleeding |
| 01/18/1996 | WO1996001276A1 Expression of a functional human type i interferon receptor |
| 01/18/1996 | WO1996001275A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 01/18/1996 | WO1996001274A1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 01/18/1996 | WO1996001273A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 01/18/1996 | WO1996001272A1 Helicobacter proteins and vaccines |
| 01/18/1996 | WO1996001271A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | WO1996001270A1 Human elastase iv |
| 01/18/1996 | WO1996001126A1 Multi-stage cascade boosting vaccine |
| 01/18/1996 | WO1996001125A1 Use of insulin and igf-i |
| 01/18/1996 | WO1996001124A1 Use of igf-i or analogues thereof in the prevention of diabetes |
| 01/18/1996 | WO1996001123A1 Combination treatment as animal growth promoter containing bovine somatotropin and an estrogenic agent |
| 01/18/1996 | WO1996001122A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 01/18/1996 | WO1996001121A1 Cancer therapy using lymphotoxin |
| 01/18/1996 | WO1996001111A1 Use of leflunomide to control and reverse chronic allograft rejection and to prevent or control xenograft rejection |
| 01/18/1996 | WO1996001102A1 Factor to grow tissue ex vivo |
| 01/18/1996 | WO1996001101A1 Desquamation compositions |
| 01/18/1996 | WO1995034320A3 Methods for inhibiting antigen specific t cell responses |
| 01/18/1996 | DE4425781A1 Technetium-Sulfonamid-Komplexe, deren Verwendung, diese enthaltende pharmazeutische Mittel, sowie Verfahren zur Herstellung der Komplexe und Mittel Technetium-sulfonamide complexes, their use, pharmaceutical compositions containing them, and processes for producing the complexes and agents |
| 01/18/1996 | DE4425255A1 Formulierung zur inhalativen Applikation Formulation for inhalation |